Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 808 entries
View as:

A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting

Phase: N/A Priority: Normal
NCT ID: NCT03291730 Org: User:
Start: 01/09/18 End: 06/05/18 Due: 06/05/19

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01783587 Org: User:
Start: 02/28/13 End: 06/01/18 Due: 06/01/19

Vitamin D for Chemoprevention

Phase: N/A Priority: Normal
NCT ID: NCT00585637 Org: User:
Start: 10/31/07 End: 12/31/13 Due: 12/31/14

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00601146 Org: User:
Start: 11/01/06 End: 12/01/19 Due: 12/01/20

Sunitinib in Never-Smokers With Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01829217 Org: User:
Start: 05/31/13 End: 01/31/18 Due: 01/31/19

Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01661868 Org: User:
Start: 08/31/12 End: 08/31/12 Due: 08/31/13

Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT03783546 Org: User:
Start: 01/15/19 End: 12/01/25 Due: 12/01/26

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02919670 Org: User:
Start: 10/31/16 End: 07/31/20 Due: 07/31/21

RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00409292 Org: User:
Start: 01/31/07 End: 05/31/09 Due: 05/31/10

Nivolumab Plus Ipilimumab in Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03246958 Org: User:
Start: 10/03/17 End: 07/31/21 Due: 07/31/22

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Phase: N/A Priority: Normal
NCT ID: NCT03113643 Org: User:
Start: 06/26/17 End: 05/31/27 Due: 05/31/28

The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06439693 Org: User:
Start: 08/08/24 End: 03/30/33 Due: 03/30/34

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03239145 Org: User:
Start: 08/31/17 End: 12/13/24 Due: 12/13/25

Cyclophosphamide and Alemtuzumab In Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03132584 Org: User:
Start: 07/30/17 End: 01/30/18 Due: 01/30/19

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Phase: N/A Priority: Normal
NCT ID: NCT02764541 Org: User:
Start: 05/24/16 End: 04/30/31 Due: 04/30/32

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Phase: N/A Priority: Normal
NCT ID: NCT04468061 Org: User:
Start: 07/20/20 End: 04/01/29 Due: 04/01/30

Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function

Phase: N/A Priority: Normal
NCT ID: NCT00525460 Org: User:
Start: 04/30/06 End: 12/31/14 Due: 12/31/15

Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00098514 Org: User:
Start: 12/31/03 End: 05/31/11 Due: 05/31/12

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05866887 Org: User:
Start: 09/26/23 End: 06/05/24 Due: 06/05/25

PROFAST Intervention in Precursor Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05565638 Org: User:
Start: 03/06/23 End: 05/31/26 Due: 05/31/27

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT04839614 Org: User:
Start: 08/01/21 End: 06/30/26 Due: 06/30/27

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02656849 Org: User:
Start: 02/29/16 End: 05/31/23 Due: 05/31/24

Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00815919 Org: User:
Start: 12/31/08 End: 01/31/13 Due: 01/31/14

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01551693 Org: User:
Start: 09/30/11 End: 09/30/12 Due: 09/30/13

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02172651 Org: User:
Start: 07/14/14 End: 06/30/26 Due: 06/30/27